RAP 0.00% 20.5¢ resapp health limited

possible future competition, page-14

  1. 239 Posts.
    lightbulb Created with Sketch. 128
    It sounds more like it's direct competition to WebMD. Which isn't a competitor at all to RAP, even though they're both in health, they're trying to serve very different markets. It's not like Doctors jump onto WebMD when trying to diagnose patients... If they did, all of us should be buying up stocks in chemotherapy suppliers.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.